Search

David A Killian

from Rye, NY
Age ~54
Get Report
Also known as:
David M Killian, David Living Fry, David A Killion, David M Amador, David A Fry, David A Krein
Related to:
David L Mccoy, 43Donald Fry, 68David A Fry, 57James Compton, 56Arnold Weiss, 81Anna Fry
Connected to:
Andrew S Killian, 45Bradley K Killian, 62Brigid K Killian, 61Britney S Killian, 35Brodie J Killian, 46Clinton O Killian, 67Dara V Killian, 36Dean R Killian, 59Desmond D Killian, 38Dianne S Killian, 88

David Killian Phones & Addresses

  • Rye, NY
  • Edgartown, MA
  • 1835 Halsted St, Chicago, IL 60614 (312) 944-1516 (773) 944-1516
  • 1133 Dearborn St, Chicago, IL 60610 (312) 944-1516
  • 1101 Lill Ave, Chicago, IL 60614 (773) 857-5126
  • New York, NY
  • Norfolk, MA
  • Westchester, NY
  • 1835 N Halsted St, Chicago, IL 60614 (773) 263-8056

Work

Company: DSKillian Roofing & General Contractors Inc Address: 3948 S. 3Rd St Jb Fl 32250 Phones: (904) 509-8470

Emails

r***[email protected]

Resumes

Resumes

David Killian Photo 1

Divemaster At The Academy Of Scuba

View page
Position:
Market Development Manager at Coca-Cola Refreshments, Divemaster at The Academy of Scuba
Location:
Phoenix, Arizona
Industry:
Food & Beverages
Work:
Coca-Cola Refreshments - Tempe/Phoenix since Nov 2011
Market Development Manager
The Academy of Scuba since Jan 2013
Divemaster
Pinnacle Peak Trading Company, LLC Oct 2007 - Oct 2011
Customer Service/Front End Operations
Boys and Girls Club - Phoenix, Arizona Jul 2007 - Nov 2007
Sports Fitness and Recreation Assistant
Boys and Girls Clubs of Greater Scottsdale - Fountain Hills, Arizona Aug 2002 - Aug 2006
Sports Staff
Education:
2006-2010 Arizona State University Hugh Downs School of Communication 2006 - 2010
BS Bachelor of Science, Communication
Skills:
Sales
David Killian Photo 2

David Killian

View page
Location:
United States
David Killian Photo 3

David Killian

View page
Location:
United States
David Killian Photo 4

Master Scheduler At Triumph Group

View page
Location:
United States
Industry:
Aviation & Aerospace
David Killian Photo 5

David Killian

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
David Killian
Religious Leader
All Saints Parish
Religious Organizations
1773 Beacon St, Brookline, MA 02445
Website: allsaintsbrookline.org
David A Killian
Manager
PLANTINGFIELD WOOD LLC
20 Meshacket Rd, Edgartown, MA 02539
2 Plantingfield Wood Ln, Edgartown, MA 02539
David Killian
Manager
VINEYARD HOLDCO, LLC
2 Plantingfield Wood Ln, Edgartown, MA 02539
1900 N Burling St, Chicago, IL 60614
David Killian
Clerk
RUAH SPIRITUALITY INSTITUTE, INC
Religious Organization
1773 Beacon St, Brookline, MA 02445
1776 Beacon St, Brookline, MA 02445
1789 Beacon St, Brookline, MA 02445
(617) 277-0036
David Killian
Religious Leader
All Saints Parish
Religious Organizations
1773 Beacon St, Brookline, MA 02445
Website: allsaintsbrookline.org

Publications

Us Patents

Compounds And Methods For The Treatment Of Inflammatory And Immune Disorders

View page
US Patent:
20020177723, Nov 28, 2002
Filed:
Apr 11, 2000
Appl. No.:
09/547941
Inventors:
Xiong Cai - Allston MA, US
Sajjat Hussoin - Lexington MA, US
David Killian - Cambridge MA, US
International Classification:
A61K031/353
A61K031/4709
C 07D 4 5/02
A61K031/34
US Classification:
549/491000, 549/493000, 549/494000, 549/414000, 546/152000, 546/283400, 514/471000, 514/459000, 514/314000, 514/336000
Abstract:
2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respiratory burst leading to the formation of damaging oxygen radicals of polymorphonuclear leukocytes during an inflammatory or immune response. The compounds exhibit this biological activity by acting as PAF receptor antagonists, by inhibiting the enzyme 5-lipoxygenase, or by exhibiting dual activity, i. e., by acting as both a PAF receptor antagonist and inhibitor of 5-lipoxygenase. A method to treat disorders mediated by PAF or leukotrienes is also disclosed, that includes administering an effective amount of one or more of the above-identified compounds or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier.

Compounds And Methods For The Treatment Of Inflammatory And Immune Disorders

View page
US Patent:
62945742, Sep 25, 2001
Filed:
Jun 6, 1995
Appl. No.:
8/469073
Inventors:
Xiong Cai - Allston MA
Sajjat Hussoin - Cambridge MA
David Killian - Cambridge MA
T. Y. Shen - Charlottesville VA
Assignee:
Cytomed, Inc. - Cambridge MA
International Classification:
A01N 4308
US Classification:
514473
Abstract:
2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respiratory burst leading to the formation of damaging oxygen radicals of polymorphonuclear leukocytes during an inflammatory or immune response. The compounds exhibit this biological activity by acting as PAF receptor antagonists, by inhibiting the enzyme 5-lipoxygenase, or by exhibiting dual activity, i. e. , by acting as both a PAF receptor antagonist and inhibitor of 5-lipoxygenase. A method to treat disorders mediated by PAF or leukotrienes is also disclosed, that includes administering an effective amount of one or more of the above-identified compounds or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier.

Compounds And Methods For The Treatment Of Disorders Mediated By Platelet Activating Factor Or Products Of 5-Lipoxygenase

View page
US Patent:
54341515, Jul 18, 1995
Filed:
Aug 24, 1992
Appl. No.:
7/933991
Inventors:
Xiong Cai - Allston MA
Sajjat Hussoin - Cambridge MA
David Killian - Cambridge MA
T. Y. Shen - Charlottesville VA
Assignee:
CytoMed, Inc. - Cambridge MA
International Classification:
A61K 31535
A01N 4340
C07D33332
C07D41300
US Classification:
5142315
Abstract:
2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respiratory burst leading to the formation of damaging oxygen radicals of polymorphonuclear leukocytes during an inflammatory or immune response. The compounds exhibit this biological activity by acting as PAF receptor antagonists, by inhibiting the enzyme 5-lipoxygenase, or by exhibiting dual activity, i. e. , by acting as both a PAF receptor antagonist and inhibitor of 5-lipoxygenase. A method to treat disorders mediated by PAF or leukotrienes is also disclosed, that includes administering an effective amount of one or more of the above-identified compounds or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier.

Compounds And Methods For The Treatment Of Disorders Mediated By Platelet Activating Factor Or Products Of 5-Lipoxygenase

View page
US Patent:
58563237, Jan 5, 1999
Filed:
Jun 7, 1995
Appl. No.:
8/481812
Inventors:
Xiong Cai - Allston MA
Sajjat Hussoin - Cambridge MA
David Killian - Cambridge MA
T. Y. Shen - Charlottesville VA
Assignee:
CytoMed, Inc. - Cambridge MA
International Classification:
A61K 31535
A61K 4340
A61K 4308
A61K 4306
US Classification:
5142315
Abstract:
2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respiratory burst leading to the formation of damaging oxygen radicals of polymorphonuclear leukocytes during an inflammatory or immune response. The compounds exhibit this biological activity by acting as PAF receptor antagonists, by inhibiting the enzyme 5-lipoxygenase, or by exhibiting dual activity, i. e. , by acting as both a PAF receptor antagonist and inhibitor of 5-lipoxygenase. A method to treat disorders mediated by PAF or leukotrienes is also disclosed, that includes administering an effective amount of one or more of the above-identified compounds or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier.

Compounds And Methods For The Treatment Of Inflammatory And Immune Disorders

View page
US Patent:
56484860, Jul 15, 1997
Filed:
May 12, 1993
Appl. No.:
8/062391
Inventors:
Xiong Cai - Allston MA
Sajjat Hussoin - Lexington MA
David Killian - Cambridge MA
T. Y. Shen - Charlottesville VA
Assignee:
CytoMed, Inc. - Cambridge MA
International Classification:
C07D33322
C07D41300
US Classification:
544124
Abstract:
2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respiratory burst leading to the formation of damaging oxygen radicals of polymorphonuclear leukocytes during an inflammatory or immune response. The compounds exhibit this biological activity by acting as PAF receptor antagonists, by inhibiting the enzyme 5-lipoxygenase, or by exhibiting dual activity, i. e. , by acting as both a PAF receptor antagonist and inhibitor of 5-lipoxygenase. A method to treat disorders mediated by PAF or leukotrienes is also disclosed, that includes administering an effective amount of one or more of the above-identified compounds or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier.

Compounds And Methods For The Treatment Of Disorders Mediated By Platelet Activating Factor Or Products Of 5-Lipoxygenase

View page
US Patent:
53589386, Oct 25, 1994
Filed:
Jul 13, 1992
Appl. No.:
7/912788
Inventors:
Xiong Cai - Allston MA
David Killian - Cambridge MA
T. Y. Shen - Charlottesville VA
Assignee:
CytoMed, Inc. - Cambridge MA
International Classification:
A61K 31535
H01N 4340
C07D33322
C07D41300
US Classification:
5142315
Abstract:
2,5-Diaryl tetrahydrofurans, 2,5-diaryl terahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiphenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respiratory burst leading to the formation of damaging oxygen radicals of polymorphonuclear leukocytes during an inflammatory or immune response. The compounds exhibit this biological activity by acting as PAF receptor antagonists, by inhibiting the enzyme 5-lipoxygenase, or by exhibiting dual activity, i. e. , by acting as both a PAF receptor antagonist and inhibitor of 5-lipoxygenase. A method to treat disorders mediated by PAF or leukotrienes is also disclosed, that includes administering an effective amount of one or more of the above-identified compounds or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier.
Control profile
David A Killian from Rye, NY, age ~54 Get Report